Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase EARLY_PHASE1 1Phase 3 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 4Gynecologic 3Breast 3Other 2Genitourinary 2Gastrointestinal 2Thoracic 1NET 1Endocrine 1CNS 1

Conditions

Thoracic Neoplasms 1

Interventions

Radiosurgery 6pembrolizumab 5Oncolytic Virotherapy 4Magnetic Resonance Spectroscopy 4Fluorodeoxyglucose F18 4Carboplatin 4Paclitaxel 3Cyclophosphamide 3Cisplatin 3osimertinib 2atezolizumab 2aldesleukin 2Tobacco Use Cessation Devices 2Specimen Handling 2Radiotherapy 2Positron-Emission Tomography 2Pemetrexed 2Nivolumab 2Docetaxel 2toripalimab 1sugemalimab 1sodium thiosulfate 1perflutren 1palbociclib 1icotinib 1gallium 68 PSMA-11 1fludarabine 1durvalumab 1dapagliflozin 1dacomitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Metformin × Thoracic × Clear all
NCT03477162 2023-10-03

Metformin Pharmacology in Human Cancers: A Proof of Principle Study

Dartmouth-Hitchcock Medical Center

Phase EARLY_PHASE1 Terminated
18 enrolled 10 charts
Thoracic

Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡